Get the Stockscreener App
3.31
1.49%
-0.05
After Hours:
3.31
Grace Therapeutics Inc stock is traded at $3.31, with a volume of 86,675.
It is down -1.49% in the last 24 hours and up +9.24% over the past month.
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
See More
Previous Close:
$3.36
Open:
$3.3
24h Volume:
86,675
Relative Volume:
1.30
Market Cap:
$51.22M
Revenue:
-
Net Income/Loss:
$-10.31M
P/E Ratio:
-4.2987
EPS:
-0.77
Net Cash Flow:
$-12.65M
1W Performance:
+2.80%
1M Performance:
+9.24%
6M Performance:
+13.36%
1Y Performance:
-15.13%
1-Day Range:
$3.295
$3.40
1-Week Range:
$3.21
$3.5401
52-Week Range:
$1.75
$4.685
Grace Therapeutics Inc Stock (GRCE) Company Profile
Name
Grace Therapeutics Inc
Sector
Industry
Phone
609-322-1602
Address
103 CARNEGIE CENTER, PRINCETON
Compare GRCE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
3.31 | 51.99M | 0 | -10.31M | -12.65M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-02-25 | Initiated | TD Cowen | Buy |
| Sep-01-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-06-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jan-13-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Aug-29-19 | Initiated | B. Riley FBR | Buy |
| Jul-18-19 | Initiated | Oppenheimer | Outperform |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Grace Therapeutics Inc Stock (GRCE) Latest News
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort - pharmiweb.com
Winners Losers: Why retail investors favor Grace Therapeutics Inc stock2025 Volume Leaders & Trade Opportunity Analysis - moha.gov.vn
Grace and Molecule.one to Transform Peptide Building Block Synthesis with AI and Automation - Yahoo Finance
Is Grace Therapeutics Inc. stock attractive for long term wealth buildingIPO Watch & Safe Capital Preservation Plans - Newser
Why Grace Therapeutics Inc. stock is popular among millennials2025 Retail Activity & Stepwise Trade Execution Plans - Newser
Grace Therapeutics (GRCE) Stock Analysis Report | Financials & Insights - Benzinga
Is Grace Therapeutics Inc. stock supported by strong fundamentalsTreasury Yields & Short-Term High Return Ideas - moha.gov.vn
What analysts say about Grace Therapeutics Inc stockHigh Frequency Trading Trends & Access High Yield Alerts - earlytimes.in
Why retail investors pile into Grace Therapeutics Inc. stockJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
Why Grace Therapeutics Inc. stock could rally in 2025Short Setup & Safe Entry Momentum Stock Tips - newser.com
Using RSI to spot recovery in Grace Therapeutics Inc.Trend Reversal & Low Volatility Stock Recommendations - newser.com
Will Grace Therapeutics Inc. stock maintain growth storyWeekly Gains Report & Expert Approved Trade Ideas - newser.com
Will Grace Therapeutics Inc. stock outperform Nasdaq index - newser.com
Can Grace Therapeutics Inc. stock rebound after recent weakness2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Will Grace Therapeutics Inc. stock outperform value stocks2025 Price Targets & Free Technical Confirmation Trade Alerts - newser.com
Grace Therapeutics Inc. stock outlook for YEARMarket Performance Summary & Community Consensus Picks - newser.com
Kempinski Grace Bay Breaks Ground on Turks and Caicos' Iconic Grace Bay Beach - Yahoo Finance
Building trade automation scripts for Grace Therapeutics Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference - The Manila Times
Grace Therapeutics (Nasdaq: GRCE) joins Craig-Hallum 16th Alpha Select Conference - Stock Titan
Can Grace Therapeutics Inc. stock resist market sell offsWeekly Trade Review & Verified Chart Pattern Trade Signals - newser.com
Grace Therapeutics Inc Stock (GRCE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):